Last August, a team of scientists from Newcastle University in northern England was granted a license to clone human embryos to develop new treatments for diabetes and degenerative diseases such as Alzheimer's and Parkinson's
(http://www.reuters.com/newsArticle.jhtml?type=hea lthNews&storyID=7569803&pageNumber=1)
Last August, a team of scientists from Newcastle University in northern England was granted a license to clone human embryos to develop new treatments for diabetes and degenerative diseases such as Alzheimer's and Parkinson's (http://www.reuters.com/newsArticle.jhtml?type=hea lthNews&storyID=7569803&pageNumber=1)